These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29438221)

  • 1. Plasma Concentration of Biomarkers Reflecting Endothelial Cell- and Glycocalyx Damage are Increased in Patients With Suspected ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock.
    Frydland M; Ostrowski SR; Møller JE; Hadziselimovic E; Holmvang L; Ravn HB; Jensen LO; Pettersson AS; Kjaergaard J; Lindholm MG; Johansson PI; Hassager C
    Shock; 2018 Nov; 50(5):538-544. PubMed ID: 29438221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines.
    Ostrowski SR; Pedersen SH; Jensen JS; Mogelvang R; Johansson PI
    Crit Care; 2013 Feb; 17(1):R32. PubMed ID: 23433357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction.
    Klein A; Wiberg S; Hassager C; Winther-Jensen M; Frikke-Schmidt R; Bang LE; Lindholm MG; Holmvang L; Moeller-Helgestad O; Ravn HB; Jensen LO; Kjaergaard J; Moeller JE; Frydland M
    Shock; 2020 Mar; 53(3):299-306. PubMed ID: 31058719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in cardiogenic shock is stronger associated to clinical factors than contemporary biomarkers reflecting neurohormonal stress and inflammatory activation.
    Josiassen J; Frydland M; Holmvang L; Lerche Helgestad OK; Okkels Jensen L; Goetze JP; Eifer Møller J; Hassager C
    Biomarkers; 2020 Sep; 25(6):506-512. PubMed ID: 32649233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock.
    Sionis A; Suades R; Sans-Roselló J; Sánchez-Martínez M; Crespo J; Padró T; Cubedo J; Ferrero-Gregori A; Vila-Perales M; Duran-Cambra A; Badimon L
    Int J Cardiol; 2018 May; 258():249-256. PubMed ID: 29544939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients.
    Obling L; Frydland M; Hansen R; Møller-Helgestad OK; Lindholm MG; Holmvang L; Ravn HB; Wiberg S; Thomsen JH; Jensen LO; Kjærgaard J; Møller JE; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):7-15. PubMed ID: 28452562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial Infarction.
    Frydland M; Møgelvang R; Møller JE; Helgestad OKL; Holmvang L; Mark PD; Jensen LO; Hassager C
    Shock; 2021 Aug; 56(2):255-259. PubMed ID: 34276039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction.
    Frydland M; Møller JE; Lindholm MG; Hansen R; Wiberg S; Lerche Helgestad OK; Thomsen JH; Goetze JP; Engstrøm T; Frikke-Schmidt R; Ravn HB; Holmvang L; Jensen LO; Kjaergaard J; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):557-566. PubMed ID: 31961195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in patients with Takotsubo cardiomyopathy compared to patients with acute anterior ST-elevation myocardial infarction.
    Højagergaard MA; Hassager C; Christensen TE; Bang LE; Gøtze JP; Ostrowski SR; Holmvang L; Frydland M
    Biomarkers; 2020 Mar; 25(2):137-143. PubMed ID: 31902247
    [No Abstract]   [Full Text] [Related]  

  • 10. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients.
    Johansson PI; Stensballe J; Rasmussen LS; Ostrowski SR
    Ann Surg; 2011 Aug; 254(2):194-200. PubMed ID: 21772125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial Injury.
    Wernly B; Fuernau G; Masyuk M; Muessig JM; Pfeiler S; Bruno RR; Desch S; Muench P; Lichtenauer M; Kelm M; Adams V; Thiele H; Eitel I; Jung C
    Sci Rep; 2019 Dec; 9(1):18367. PubMed ID: 31797997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission biomarkers among patients with acute myocardial-infarction related cardiogenic shock with or without out-of-hospital cardiac arrest an exploratory study.
    Thøgersen M; Frydland M; Lerche Helgestad OK; Okkels Jensen L; Josiassen J; Goetze JP; Møller JE; Hassager C
    Biomarkers; 2021 Nov; 26(7):632-638. PubMed ID: 34259098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STEMI, Cardiogenic Shock, and Mortality in Patients Admitted for Acute Angiography: Associations and Predictions from Plasma Proteome Data.
    Debrabant B; Halekoh U; Soerensen M; Møller JE; Hassager C; Frydland M; Palstrøm N; Hjelmborg J; Beck HC; Rasmussen LM
    Shock; 2021 Jan; 55(1):41-47. PubMed ID: 32590698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.
    van Diepen S; Alemayehu WG; Zheng Y; Theroux P; Newby LK; Mahaffey KW; Granger CB; Armstrong PW
    J Thromb Thrombolysis; 2016 Oct; 42(3):376-85. PubMed ID: 27324144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intra-aortic balloon pump on short-term clinical outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock: A "real life" single center experience.
    de la Espriella-Juan R; Valls-Serral A; Trejo-Velasco B; Berenguer-Jofresa A; Fabregat-Andrés Ó; Perdomo-Londoño D; Albiach-Montañana C; Vilar-Herrero JV; Sanmiguel-Cervera D; Rumiz-Gonzalez E; Morell-Cabedo S
    Med Intensiva; 2017 Mar; 41(2):86-93. PubMed ID: 27650459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study.
    Ostrowski SR; Sørensen AM; Windeløv NA; Perner A; Welling KL; Wanscher M; Larsen CF; Johansson PI
    Scand J Trauma Resusc Emerg Med; 2012 Apr; 20():27. PubMed ID: 22490186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of the endothelial glycocalyx in cardiogenic shock and its prognostic relevance.
    Jung C; Fuernau G; Muench P; Desch S; Eitel I; Schuler G; Adams V; Figulla HR; Thiele H
    Shock; 2015 May; 43(5):450-5. PubMed ID: 25692257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathoadrenal activation and endothelial damage are inter correlated and predict increased mortality in patients resuscitated after out-of-hospital cardiac arrest. a post Hoc sub-study of patients from the TTM-trial.
    Johansson PI; Bro-Jeppesen J; Kjaergaard J; Wanscher M; Hassager C; Ostrowski SR
    PLoS One; 2015; 10(3):e0120914. PubMed ID: 25789868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiogenic shock with ST-segment elevation acute coronary syndrome (ReNa-Shock ST).
    Castillo Costa Y; Mauro VM; García Aurelio M; Barrero C; Charask A; Gagliardi JA
    Medicina (B Aires); 2017; 77(4):261-266. PubMed ID: 28825567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.